UK Stem Cell Vote: It's decision time for 'hybrid' human-animal embryos
By Marisa Taylor,
Red Herring
| 01. 05. 2007
[Quotes CGS's Marcy Darnovsky]
The United Kingdom's regulatory body for stem cell and fertility research will vote Wednesday to determine whether a team of British scientists should be allowed to use animal eggs in human embryonic stem cell research. And like a science fiction movie gone awry, the public frenzy has reached fever pitch over the research that critics say crosses the delicate human-animal divide.
Chris Shaw, a neurology professor at King's College London, and Ian Wilmut, the Edinburgh University scientist famous for cloning Dolly the sheep, have submitted a proposal to the U.K.'s Human Fertilization and Embryology Authority (HEFA) to use a process called cell nuclear replacement for the production of stem cell lines. Human DNA would be implanted into an animal egg so that it starts dividing, and then removed from the animal egg to be grown into different kinds of stem cells.
The scientists say that the use of animal eggs to create human stem cells could be beneficial in that the process avoids the use of human eggs or fetuses. But the possibility of using animal eggs to host human...
Related Articles
By Isaac Schultz, Gizmodo | 10.18.2024
Colossal Biosciences, a company mainly known for intending to genetically engineer proxies for several iconic extinct species, announced this week that it has made major steps towards the de-extinction of the thylacine, or Tasmanian tiger.
The thylacine was a carnivorous...
By Russ Burlingame, Comicbook | 07.23.2024
Colossal Laboratories and Biosciences, a biotech company that's putting together plans to orchestrate the de-extinction for animals like the dodo and the wooly mammoth, made some waves on Reddit recently when they petitioned the United Federation of Planets -- the...
By Shelly Fan, Singularity Hub | 05.31.2024
We all know the drill for reproduction—sperm meets egg.
For the past decade, scientists have been pushing the boundaries of where the two halves come from. Thanks to induced pluripotent stem cell technology, it’s now possible to scrape skin cells...
By Alison Snyder, Axios | 06.06.2024
Gene editing's next chapter will be focused on tackling cancers and more common diseases, uncovering new details about aging and other fundamental aspects of biology and editing RNA, top scientists in the field said this week.
The big picture: ...